NIH: Office of Disease Prevention

Menu

Current Funding Opportunity Announcements

In collaboration with the FDA Center for Tobacco Products, NIH is increasing its portfolio to support the scientific needs of the Center. Below you will find a listing of funding opportunities that are currently accepting applications. Investigator initiated applications may also be submitted for review. Refer to the Research Priorities page for topics relevant to FDA. Interested applicants should work with their NIH Program Officials or Contact Us.

For a list of closed request for applications and program announcements, visit the Archive of Funding Opportunities.

Title Announcement # Receipt Date(s)
Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)

Frequently Asked Questions
(PDF - 44 KB, updated March 22, 2017)
RFA-OD-17-002 (U54)

Pre-application webinar to be held March 27, 2017, 11:00 a.m. to 12:30 p.m. ET
July 19, 2017
Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)

Frequently Asked Questions
(PDF - 71 KB, updated March 22, 2017)
RFA-OD-17-003 (U54)

Pre-application webinar to be held March 27, 2017, 3:00 p.m. to 4:30 p.m. ET
July 19, 2017
Notice of Intent to Publish a Funding Opportunity Announcement for the Center for Coordination of Analytics, Science, Training, and Logistics (CASTL) in Tobacco Regulatory Science (U54) NOT-OD-16-150 (U54) Applications are not being solicited at this time.
Notice of Intent to Publish a Funding Opportunity Announcement for the Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54) NOT-OD-16-151 (U54) Applications are not being solicited at this time.

Who is eligible for an NIH-FDA Grant?

Each type of NIH grant program has its own set of eligibility requirements. Applicants can find eligibility information in section III of each funding opportunity announcement (FOA). While the principal investigator (PI) conceives and writes the application, NIH recognizes the applicant institution as the grantee for most grant types.

FDA CTP funds can support awards to foreign institutions, international organizations, and domestic institutions with foreign components. For purposes of this policy, a “foreign component” is defined as performance of any significant element or segment of the project outside the United States (U.S.) either by the grantee or by a researcher employed by a foreign institution, whether or not grant funds are expended. Proposed research must contribute to the US tobacco regulatory science.

Application Submission & Review